JPWO2021215517A1 - - Google Patents
Info
- Publication number
- JPWO2021215517A1 JPWO2021215517A1 JP2022517104A JP2022517104A JPWO2021215517A1 JP WO2021215517 A1 JPWO2021215517 A1 JP WO2021215517A1 JP 2022517104 A JP2022517104 A JP 2022517104A JP 2022517104 A JP2022517104 A JP 2022517104A JP WO2021215517 A1 JPWO2021215517 A1 JP WO2021215517A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020076370 | 2020-04-22 | ||
| JP2020174820 | 2020-10-16 | ||
| PCT/JP2021/016372 WO2021215517A1 (ja) | 2020-04-22 | 2021-04-22 | 新型コロナウイルス感染症（ｃｏｖｉｄ－１９）の治療及び／又は予防剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2021215517A1 true JPWO2021215517A1 (https=) | 2021-10-28 |
Family
ID=78269312
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022517104A Pending JPWO2021215517A1 (https=) | 2020-04-22 | 2021-04-22 | |
| JP2021072865A Active JP7058026B2 (ja) | 2020-04-22 | 2021-04-22 | 新型コロナウイルス感染症（ｃｏｖｉｄ－１９）の治療及び／又は予防剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021072865A Active JP7058026B2 (ja) | 2020-04-22 | 2021-04-22 | 新型コロナウイルス感染症（ｃｏｖｉｄ－１９）の治療及び／又は予防剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230190690A1 (https=) |
| EP (1) | EP4140479A4 (https=) |
| JP (2) | JPWO2021215517A1 (https=) |
| CN (1) | CN115768415A (https=) |
| WO (1) | WO2021215517A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240189269A1 (en) * | 2021-03-26 | 2024-06-13 | Tokyo Institute Of Technology | Pharmaceutical composition for suppressing tmprss2 expression |
| WO2024210119A1 (ja) * | 2023-04-03 | 2024-10-10 | 国立大学法人 長崎大学 | 化学感覚障害の予防又は治療用組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5895786A (en) * | 1996-05-08 | 1999-04-20 | New York Blood Center, Inc. | Method for treating viral infections |
| EP1591117A4 (en) | 2003-02-04 | 2006-04-26 | Yakult Honsha Kk | BCRP (BREAST CANCER RESISTANCE PROTEIN) INHIBITOR |
| US20060135445A1 (en) | 2003-02-04 | 2006-06-22 | Kabushiki Kaisha Yakult Honsha | Breast cancer-resistant protein inhibitor |
| NZ562143A (en) | 2005-03-30 | 2010-12-24 | Yakult Honsha Kk | Dimethoxyphenyl-acrylonitrile derivatives and uses thereof in the treatment of cancer |
| KR20100100826A (ko) | 2007-12-03 | 2010-09-15 | 가부시끼가이샤 야구르트혼샤 | Ａｂｃｇ2 저해제 |
| WO2014013664A1 (ja) * | 2012-07-19 | 2014-01-23 | Ｓｂｉファーマ株式会社 | インフルエンザウイルス感染症の予防・治療剤 |
| MX2015016326A (es) | 2013-06-18 | 2016-03-03 | Nestec Sa | Unidad de filtro para una capsula. |
| HK1246682A1 (en) * | 2015-04-10 | 2018-09-14 | Sbi Pharmaceuticals Co., Ltd. | Prophylactic/therapeutic agent for virus infections which comprises ala compound |
| JPWO2020218577A1 (https=) * | 2019-04-26 | 2020-10-29 | ||
| US10987329B1 (en) | 2020-04-22 | 2021-04-27 | Nadimpally Satyavarahala Raju | Combination therapy for coronavirus infections including the novel corona virus (COVID-19) |
| US11883376B2 (en) | 2020-04-22 | 2024-01-30 | Nadimpally Satyavarahala Raju | Viral infection treatment with 5-aminolevulinic acid |
-
2021
- 2021-04-22 JP JP2022517104A patent/JPWO2021215517A1/ja active Pending
- 2021-04-22 CN CN202180029760.3A patent/CN115768415A/zh active Pending
- 2021-04-22 WO PCT/JP2021/016372 patent/WO2021215517A1/ja not_active Ceased
- 2021-04-22 US US17/920,703 patent/US20230190690A1/en active Pending
- 2021-04-22 EP EP21792108.9A patent/EP4140479A4/en not_active Withdrawn
- 2021-04-22 JP JP2021072865A patent/JP7058026B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021215517A1 (ja) | 2021-10-28 |
| JP2022008060A (ja) | 2022-01-13 |
| EP4140479A4 (en) | 2024-05-29 |
| EP4140479A1 (en) | 2023-03-01 |
| CN115768415A (zh) | 2023-03-07 |
| JP7058026B2 (ja) | 2022-04-21 |
| US20230190690A1 (en) | 2023-06-22 |